Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
09/2003
09/04/2003WO2003072708A2 Pluripotent cells comprising allogenic nucleus and mitochondria
09/04/2003WO2003072698A2 Surface proteins of leptospira
09/04/2003WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
09/04/2003WO2002046237A3 Humanized antibodies that recognize beta amyloid peptide
09/04/2003US20030166273 Culturing in a medium containing vascular endothelial cell growth factor, fibroblast growth factor, insulin-like growth factor and epidermal growth factor; inducing blood vessel formation when transplanted in vivo
09/04/2003US20030166236 Obtained from Trichoderma; high temperature/ph production; papermaking/bleaching
09/04/2003US20030165496 Alzheimer's disease
09/04/2003CA2477459A1 Comparative field analysis (comfa) utilizing topomeric alignment of molecular fragments
09/03/2003EP1339868A2 Methods for isolating centromere dna
09/03/2003EP0711349B1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
09/03/2003CN1439646A Method for segregating nucleic acid
08/2003
08/28/2003WO2003070905A2 Electroporation methods for introducing bioactive agents into cells
08/28/2003WO2003070902A2 Receptors and membrane-associated proteins
08/28/2003WO2003070889A2 Prostate specific genes and the use thereof in design or therapeutics
08/28/2003WO2003070883A2 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
08/28/2003US20030162266 When the primers hybridize to each other, the 3' terminal residue of one primer forms a mismatch with the altered or mutated nucleotide residue on the other primer, thus preventing primer extension
08/28/2003CA2476452A1 Electroporation methods for introducing bioactive agents into cells
08/21/2003WO2003068928A2 Gene function inferring using gene expression data
08/21/2003WO2003068923A2 Signal for packaging of influenza virus vectors
08/21/2003WO2003068907A2 Method for the generation of proteins with new enzymatic function
08/21/2003WO2003068819A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003WO2003029425A3 Whole cell engineering using real-time metabolic flux analysis
08/21/2003WO2003008539A3 Non-alloying core shell nanoparticles
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003CA2492097A1 Signal for packaging of influenza virus vectors
08/21/2003CA2473816A1 Gene function inferring using gene expression data
08/21/2003CA2471392A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/20/2003EP1335738A2 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
08/20/2003CN1118572C G-CSF analogue compisition, and preparing process thereof
08/20/2003CN1118571C Active protein with thrombopoietin
08/19/2003US6608241 Protection of plants against viral infection
08/19/2003CA2012414C Hog cholera virus vaccine and diagnostic
08/14/2003WO2003066817A2 Compositions and methods for rolling circle amplification
08/14/2003WO2003066812A2 Substituted 4,4-difluoro-4-bora-3a, 4a-diaza-s-indacene compounds for 8-color dna sequencing
08/14/2003WO2003066801A2 Method for specific integration of t7 rna polymerase gene in the chromosome of corynebacterial and the resultant corynebacteria-t7 promoter based shuttle vector system.
08/14/2003US20030152940 Vectors comprise avian lysozyme leader peptide for targetting the endoplasmic reticulum; heparin affinity chromatography
08/14/2003US20030151735 Scanning of biological samples
08/14/2003CA2473865A1 Compositions and methods for rolling circle amplification
08/13/2003EP1334981A2 Method for purifying keratinocyte growth factors
08/12/2003US6605449 Saturation mutagenesis to produce progenitor polynucleotide library
08/07/2003WO2003064626A2 Double-stranded oligonucleotides
08/07/2003WO2003064625A2 Oligonucleotide compositions with enhanced efficiency
08/07/2003WO2003064624A2 Molecular hepatotoxicology modeling
08/07/2003WO2003064615A2 Amplifying repetitive nucleic acid sequences
08/07/2003US20030149420 Method and apparatus for treating bodily tissues with medicinal substance
08/07/2003CA2475003A1 Double-stranded oligonucleotides
08/07/2003CA2474910A1 Oligonucleotide compositions with enhanced efficiency
08/07/2003CA2474468A1 Amplifying repetitive nucleic acid sequences
08/07/2003CA2471661A1 Molecular hepatotoxicology modeling
08/06/2003CN1434832A DNA for encoding the RGI polypeptide
08/06/2003CN1434116A Streptomyces ces virdocyaneus sp nov
08/06/2003CN1434115A Streptomycete albogriseus spnov
08/05/2003US6602711 Removing the adhering colonies from the substrate in clumps; incubating in a container and allowing them to coalesce; useful for drug discovery, toxicity screens, and will provide a source of cells for transplantations
08/05/2003US6602706 Cell comprising nucleotide sequence encoding viral gene product and recombinant nucleic acids lacking overlapping sequences; virus unable to replicate; use in treatment of genetic disorders and autoimmune diseases; antitumor agent
07/2003
07/31/2003WO2003062389A2 UNIVERSAL RT-COUPLED PCR METHOD FOR THE SPECIFIC AMPLIFICATION OF mRNA
07/31/2003WO2003062369A2 Expansion of renewable stem cell populations
07/31/2003WO2003044178A3 Hybrid oligonucleotide primers for amplification of dna and uses thereof
07/31/2003WO2003031571A3 Novel human proteins, polynucleotides encoding them and methods of using the same
07/31/2003WO2002024909A3 Receptor nucleic acids and polypeptides
07/31/2003US20030143599 Attaching a primer; ligation of an adaptor sequence or homopolymeric tailing with terminal deoxynucleotidyltransferase
07/31/2003CA2474344A1 Expansion of renewable stem cell populations
07/30/2003CN1433267A High purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa
07/24/2003WO2003060090A2 Novel cytokine zcytor17 ligand
07/24/2003US20030140366 Regulation of quinolate phosphoribosyl transferase expression
07/24/2003US20030138828 Compositions and methods of selective nucleic acid isolation
07/23/2003EP1329499A2 Growth factor-responsive progenitor cells which can be proliferated in vitro
07/23/2003EP0658203B1 Modified fungal cells and method for producing recombinant products
07/23/2003EP0586607B1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2
07/17/2003WO2003058199A2 Arrays of microparticles and methods of preparation thereof
07/17/2003WO2003031595A3 Molecules for disease detection and treatment
07/17/2003US20030135038 Magnetic pigment
07/17/2003US20030134421 Methods for mutating genes in cells and animals using insertional mutagenesis
07/17/2003US20030134353 Recombinant dimorphic fungal cell
07/17/2003US20030134322 Solid phase thermoplastic or thermosetting resin substrate having a DNA or RNA embedded therein for hybridization assays and immunoassays to detect antinucleic acid antibody
07/17/2003US20030134318 Methods of using randomized libraries of zinc finger proteins for the identification of gene function
07/17/2003US20030134313 Polynucleotide containing nucleotide sequences encoding an aveC gene product, which polynucleotide molecule can be used to alter the ratio or amount of class 2:1 avermectins produced in fermentation culture of Streptomyces avemitilis
07/17/2003US20030134303 Adenine nucleotide-binding protein-directed probes, and methods of their synthesis and use
07/17/2003US20030134263 Controlling gene expression; transfection of cell
07/16/2003EP1326897A2 Humanized anti-lt-beta-r antibodies
07/15/2003US6593290 Treatment of inner ear hair cells
07/15/2003US6593133 Neurotrophic factors
07/10/2003WO2003055978A2 Gene recombination and hybrid protein development
07/10/2003US20030129636 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
07/10/2003US20030129635 Polynucleotide comprising the complete aveC ORF of S. avermitilis, that lacks the next complete ORF that is located downstream from the aveC ORF in situ in the S. avermitilis chromosome.
07/10/2003US20030129608 Non-alloying core shell nanoparticles
07/08/2003US6590076 Isolated polypeptide, of given sequence, comprising at least an immunogenic portion of a tumor antigen; may be used to generate antibodies
07/03/2003WO2003054143A2 Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
07/03/2003US20030124607 Methods related to streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
07/01/2003US6586661 Regulation of quinolate phosphoribosyl transferase expression by transformation with a tobacco quinolate phosphoribosyl transferase nucleic acid
07/01/2003US6586570 Compositions and methods for the treatment and diagnosis of breast cancer
07/01/2003US6585981 The Mycoplasma hyopneumoniae grows at 34 degrees C. but does not grow at 38.5 - 39.5 degrees C.
07/01/2003CA2080548C Monoclonal antibodies to hepatitis c virus
06/2003
06/26/2003WO2003052052A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
06/26/2003WO2003052049A2 Molecules for disease detection and treatment
06/26/2003US20030120052 Human genetic engineering; cancer diagnosis; hybrid nucleic acid
06/26/2003US20030118677 Method of isolating extract from the euphorbaciae obesa plant and methods for using the same
06/25/2003EP1321523A2 Selection marker gene free recombinant strains; a method for obtaining them and the use of these strains
06/25/2003CN1426423A Humanized antibodies that sequester amyloid beta peptide
06/19/2003WO2003050267A2 Method of isolating extract from the euphorbaciae obesa plant and methods for using the same
06/19/2003WO2003050264A2 Method for the analysis of differential gene expression
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 100